Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal prilocaine ED50 study for anterior-approach total hip arthroplasty
NL-OMON42912Phase 4Active, not recruiting
- Sponsor
- Reinier de Graaf Hospital
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of prilocaine in hip osteoarthritis, sponsored by Reinier de Graaf Hospital. Primary endpoint: Median effective dose (ED50) of intrathecal prilocaine. Started Sep 2016; status: active, not recruiting.
02
Drugs
prilocaine
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on NL-OMON42912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42912.